Activities and characteristics of transfer factors

Peterson EA, Greenberg LE, Manzara T, Rozzo SJ & Kirkpatrick CH. Selective removal of transfer factor activity with antigen. In: Immunobiology of Transfer Factor. New York: Academic Press, 1983: 65–74.

Kirkpatrick CH, Rozzo SJ & Mascali JJ. Murine transfer factor. III. Specific interactions between transfer factor and antigen. J Immunol 1985; 135: 4027–33.

Borkowsky W & Lawrence HS. Deletions of antigen-specific activity from leukocyte dialysates containing transfer factor by antigen- coated polystyrene. J Immunol 1981; 126: 486–89.

Rozzo SJ & Kirkpatrick CH Purification of transfer factors. Mol Immunol 1992; 29: 167–82.

Steele RW, Myers MG & Vincent MM. Transfer factor for the prevention of varicella zoster in childhood leukemia. N Engl J Med 1980; 303: 355–59.

Dwyer JM: The use of antigen-specific transfer factor in the management of infections with herpes viruses. In: Immunobiology of Transfer Factor. New York: Academic Press, 1983: 233–43.

Viza D, Rosenfeld F, Phillips J, Vich JM, Denis J, Bonissent JF & Dogbe K. Specific bovine transfer factor for the treatment of herpes infections. In: Immunobiology of Transfer Factor. New York: Academic Press, 1983: 245–58.

Kirkpatrick CH & Greenberg LE. Treatment of chronic mucocutaneous candidiasis with transfer factor. In: Immunobiology of Transfer Factor. New York: Academic Press, 1983: 547–62.

Jeter WS, Kibler R & Stephens CAL. J Reticuloend Soc 1977; 22: 46a.

Jeter WS, Kibler R, Soli TC & Stephens CAL. Oral administration of bovine and human dialyzable transfer factor to human volunteers. In: Immune Regulators in Transfer Factor. New York: Academic Press, 1979: 452–58.

Burger DR, Klesius PH, Vandenbark AA, Vetto RM & Swann AI. Transfer of keyhole limpet hemocyanin dermal reactivity to man with bovine transfer factor. Cell Immunol 1979; 43: 192–96.

Viza D, Vich JM, Phillips J & Rosenfeld F. Orally administered specific transfer factor for the treatment of herpes infections. Lymphok Res 1985; 4: 27–30.

McMeeking A, Borkowski W, Klesius PH, Bonk S, Holzman RS & Lawrence HS. A controlled trial of bovine dialyzable leukocyte extract for cryptosporidiosis in patients with AIDS. J Infec Dis 1990; 161: 108–12.

Petersen EA, Greenberg LE, Manzara T & Kirkpatrick CH. Murine transfer factor. I. Description of the model and evidence for specificity. J Immunol 1981; 126: 2480–84.

Jones JF, Minnich LL, Jeter WS, Pritchett RF, Fulginiti VA & Wedgwood RJ. Treatment of childhood combined Epstein-Barr virus/ cytomegalovirus infection with oral bovine transfer factor. Lancet 1981; 2: 122–24.

Jones JF, Schumacher MJ, Jeter WS & Hicks MJ. Oral-bovine transfer factor (OTF) use in the hyper-IgE syndrome. In: Immunobiology of Transfer Factor. New York: Academic Press, 1983: 261–70.

Weiner HL, Mackin GA, Matsui M, Orav EJ, Khoury SJ, Dawson DM & Hafler DA. Double blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 1993; 259: 1321–24.

Trentham DE, Dynesius-Trentham RA, Orav EJ, Combitichi D, Lorenzo C, Sewell KL, Hafler DA & Weiner HL. Effects of oral administration of type II collagen on rheumatoid arthritis. Science 1993; 261: 1727–30.

Alvarez-Thull L & Kirkpatrick CH. Profiles of cytokine production in recipients of transfer factors. Biotherapy, 1996; 9: 55–59.

Gottlieb AA, Foster LF & Waldman SR. What is transfer factor? Lancet 1973; 2: 822–23.

Burger DR, Wampler P, Vandenbark AA & Vetto RM. A structural model for human transfer factor suggested by enzymatic susceptibilities. In: Immune Regulators in Transfer Factors. New York: Academic Press, 1979: 377–85.

Wilson GB, Morin ML, Stuart LD, Williams AM, Floyd E, Paddock GV, Just L & Fudenberg HH. Transfer of cell-mediated immunity in vitro to human lymphocytes using dialyzable leukocyte extracts from immune burros. In: Immunobiology of Transfer Factor. New York: Academic Press, 1983: 213–29.